Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/β-catenin pathway

Yi-Bo Wu,Shen-Yi Li,Jin-Yan Liu,Jia-Jia Xue,Jin-Fu Xu,Ting Chen,Tian-Yue Cao,Hui Zhou,Tian-Tian Wu,Chun-Lin Dong,Wei-Feng Qian,Long-Wei Qiao,Shun-Yu Hou,Ting Wang,Cong Shen
DOI: https://doi.org/10.1038/s41419-023-06214-z
2023-10-24
Abstract:Abstract As a common malignant tumor among women, ovarian cancer poses a serious threat to their health. This study demonstrates that long non-coding RNA NRSN2-AS1 is over-expressed in ovarian cancer tissues using patient sample and tissue microarrays. In addition, NRSN2-AS1 is shown to promote ovarian cancer cell proliferation and metastasis both in vitro and in vivo. Mechanistically, NRSN2-AS1 stabilizes protein tyrosine kinase 2 (PTK2) to activate the β-catenin pathway via repressing MG-53-mediated ubiquitinated degradation of PTK2, thereby facilitating ovarian cancer progression. Rescue experiments verify the function of the NRSN2-AS1/PTK2/β-catenin axis and the effects of MG53 on this axis in ovarian cancer cells. In conclusion, this study demonstrates the key role of the NRSN2-AS1/PTK2/β-catenin axis for the first time and explores its potential clinical applications in ovarian cancer.
cell biology
What problem does this paper attempt to address?